LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 146 filers reported holding LOXO ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $9,805,000 | -18.0% | 70,000 | 0.0% | 2.13% | +7.9% |
| Q3 2018 | $11,958,000 | -8.1% | 70,000 | -6.7% | 1.98% | -9.0% |
| Q2 2018 | $13,011,000 | +32.7% | 75,000 | -11.8% | 2.17% | +14.9% |
| Q1 2018 | $9,806,000 | +37.1% | 85,000 | 0.0% | 1.89% | +36.1% |
| Q4 2017 | $7,155,000 | -37.9% | 85,000 | -32.0% | 1.39% | -30.9% |
| Q3 2017 | $11,515,000 | -10.2% | 125,000 | -21.9% | 2.01% | -11.4% |
| Q2 2017 | $12,830,000 | -15.3% | 160,000 | -55.6% | 2.27% | +60.1% |
| Q1 2017 | $15,148,000 | +162.0% | 360,000 | +100.0% | 1.42% | +25.1% |
| Q4 2016 | $5,781,000 | +22.7% | 180,000 | 0.0% | 1.13% | +31.1% |
| Q3 2016 | $4,712,000 | +7.0% | 180,000 | -5.3% | 0.86% | -8.2% |
| Q2 2016 | $4,404,000 | -19.5% | 190,000 | -5.0% | 0.94% | -18.0% |
| Q1 2016 | $5,468,000 | +83.1% | 200,000 | +90.5% | 1.15% | +95.6% |
| Q4 2015 | $2,987,000 | +127.8% | 105,000 | +40.0% | 0.59% | +131.1% |
| Q3 2015 | $1,311,000 | -3.0% | 75,000 | 0.0% | 0.25% | +32.3% |
| Q2 2015 | $1,352,000 | +44.8% | 75,000 | 0.0% | 0.19% | +48.8% |
| Q1 2015 | $934,000 | +6.0% | 75,000 | 0.0% | 0.13% | +7.5% |
| Q4 2014 | $881,000 | – | 75,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|